Opinion|Videos|March 28, 2025
Managing Symptoms and Quality of Life During HER2-Targeted Therapy for Upper GI Cancer
Experts discuss how to manage fatigue, abdominal pain, and other treatment-related symptoms to maintain or improve quality of life for patients undergoing HER2-targeted therapy and share strategies for supporting patients with declining performance status (eg, ECOG performance status [PS] 2) in balancing treatment efficacy with daily functioning.
Advertisement
Episodes in this series
Video content above is prompted by the following:
• How do you manage fatigue, abdominal pain, and other treatment-related symptoms to maintain or improve quality of life for patients undergoing HER2-targeted therapy?
• What strategies do you use to support patients with declining performance status (eg, ECOG PS 2) in balancing treatment efficacy with daily functioning ?
Advertisement
Related to this article
Interim AYA-NAV data show most navigation components reached young patients with cancer as designed, though full sessions lagged during treatment.
As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Ellery Palanuk, MSN, RN, CN-BN, explains how navigators rely on multidisciplinary teams and tumor boards as breast cancer treatment evolves.
At EONS 2026, a City of Hope nurse practitioner explains how shifting immunotherapy from infusion to injection can free nurse and chair time.
Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and individualized screening plans.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Daraxonrasib and RAS Inhibition: What Oncology Nurses Need to Know
2
Childhood Leukemia Treatment Disrupts Work, Finances for Most Families
3
Inside an APP-Led Outpatient Clinic for Bispecific Step-Up Dosing
4
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
5